Close Menu

    Closings

    Facebook X (Twitter) Instagram
    • Personalities/Staff
    • Jobs
    • Calendar
    • Contest Rules
    • Contact Us
    • Privacy Policy
    • Login
    RSS Facebook X (Twitter)
    News Radio KMAN
    • Local/State News
      • Manhattan
      • Wamego
      • Riley County
      • Pottawatomie County
      • Fort Riley
      • Geary County
      • State News
      • RCPD Reports
    • Weather
    • Sports
      • K-State Sports
      • High School Sports
        • HS Basketball Schedule & Scores
          • Manhattan High
          • Wamego
          • Rock Creek
          • Riley County
          • Frankfort
          • Blue Valley High
      • Scoreboard Saturday
      • Student-Athlete of the Week
    • Podcasts
      • Within Reason with Mike Matson
      • The Game
      • Wildcat Insider
      • Scoreboard Saturday
    • Obituaries
    • Message Us
      • Birthday/Anniversary
    • Keep It Local
    Listen
    Closings And Delaystyle=
    News Radio KMAN
    You are at:Home»Local News»K-State Activity»$3.7 million NIH grant to support K-State researchers in development of COVID-19 treatment

    $3.7 million NIH grant to support K-State researchers in development of COVID-19 treatment

    0
    By Brandon Peoples on August 20, 2021 K-State Activity, Local News
    Kyeong-OK “KC” Chang, virologist with Kansas State University’s College of Veterinary Medicine, recently received a $3.7 million grant to further development of COVID-19 therapeutic treatment. (Photo courtesy K-State Marketing and Communications)

    Kansas State University has received a five-year, $3.7 million grant from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases to research a new treatment method for COVID-19.

    According to a release from the university Friday, the principal investigator for the project is Virologist with the K-State College of Veterinary Medicine Kyeon-OK Chang. The project aims to complete development of a drug for pre-clinical studies, ultimately leading to a COVID-19 specific antiviral therapeutic treatment.

    Chang says “there is currently an urgent and unmet need for the discovery and development of antiviral therapeutics for the treatment of SARS-CoV-2.

    Chang’s group has been working on antiviral drug development against both human and animal coronaviruses for over a decade, with a focus on protease inhibitors.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Brandon Peoples
    • Website

    KMAN News Director and host of In Focus. Contact Brandon at Brandon@1350KMAN.com

    Related Posts

    Chipotle planning new location in Manhattan

    37-year-old arrested after stalking ex-wife to courthouse

    RCPD officer arrested on charges of unlawful computer acts, placed on leave

    Listen Live Here
    Listen Live - Mobile

    Categories

    EEO Report

    FCC Public File

    FCC Applications


    Follow @1350kman on Twitter · Manhattan Broadcasting Company is an equal opportunity employer.
    Manhattan Broadcasting does not discriminate in sale of advertising on the basis of race, gender, or ethnicity, and will not accept advertising which does so discriminate. © 2024 Manhattan Broadcasting Company.

    Follow @1350kman on Twitter · Manhattan Broadcasting Company is an equal opportunity employer.
    Manhattan Broadcasting does not discriminate in sale of advertising on the basis of race, gender, or ethnicity, and will not accept advertising which does so discriminate. © 2024 Manhattan Broadcasting Company.

    Type above and press Enter to search. Press Esc to cancel.